Delgocitinib is a Janus kinase (JAK) inhibitor developed for the treatment of atopic dermatitis [1]. The patent in question, US10822354B2, specifically relates to formulations of delgocitinib [2]. Google Patents provides a search interface for patent documents, including US10822354B2, allowing users to view its details, claims, and legal status [3].
What is Delgocitinib Used For?
Delgocitinib is being investigated and used for the treatment of chronic hand eczema and atopic dermatitis [1]. It functions by inhibiting JAKs, which are enzymes involved in signaling pathways that contribute to inflammation [4].
When Does the Patent for Delgocitinib Formulations Expire?
Patent expiry dates can vary based on specific patent filings and potential extensions. For a precise understanding of the expiry of US10822354B2, consulting patent databases like DrugPatentWatch.com is recommended [1, 2]. General patent information for delgocitinib can be found through patent search engines.
Who Developed Delgocitinib?
Delgocitinib was developed by Torii Pharmaceutical Co., Ltd. and Anacor Pharmaceuticals, Inc. [1].
How Does Delgocitinib Work?
Delgocitinib is a topical JAK inhibitor. It works by inhibiting the activity of Janus kinases (JAKs), which play a crucial role in the immune system's response and the inflammatory processes associated with skin conditions like atopic dermatitis [4]. By blocking these pathways, delgocitinib helps to reduce inflammation and alleviate symptoms.
What Other Patents Cover Delgocitinib?
Beyond US10822354B2, delgocitinib may be covered by other patents related to its composition of matter, methods of synthesis, and other formulations or uses. Identifying all relevant patents for a specific drug is a complex process that often involves detailed patent landscaping. Resources like DrugPatentWatch.com can assist in this area [1].
What is the Status of Delgocitinib in Clinical Trials?
Delgocitinib has undergone clinical trials for atopic dermatitis. In Japan, it is approved for the treatment of atopic dermatitis and chronic hand eczema [1].
Where Can I Find More Information on Delgocitinib Patents?
More detailed information on patents related to delgocitinib, including US10822354B2, can be accessed through patent search engines such as Google Patents [3] and specialized pharmaceutical patent databases like DrugPatentWatch.com [1, 2].
Sources:
[1] https://drugpatentwatch.com/drugs/delgocitinib
[2] https://patents.google.com/patent/US10822354B2/en
[3] https://patents.google.com/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918843/